Clinical trial
Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously…
NCT00128882 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00128882 |
|---|---|
| Title | Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D |
| Official title | Treatment of Idiopathic Thrombocytopenic Purpura in Children With Subcutaneously Administered Anti-D |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Kjaersgaard, Mimi, M.D. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Thrombocytopenic Purpura |
| Intervention type | Drug |
| Interventions | Anti-D |
| Enrollment | 45 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 10, 2005 |
| Last update posted | Feb 3, 2009 |
| Countries | Denmark |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: